Evidence map›Paper›PMID 29976595›Full record

ArticleJournal of clinical microbiology2018

Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.

Stefan E Richter, Loren Miller, Daniel Z Uslan, Douglas Bell, Karol Watson, Romney Humphries, James A McKinnell

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Study of Colistin Resistant Gram Negative Organism in Hospitalized Patients: A Retrospective Study.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  6. Photophysical characterization of tetrahydroxyphenyl porphyrin Zn(II) and V(IV) complexes: experimental and DFT study.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Article
  7. Article
  8. Article
  9. Antimicrobial stewardship in the intensive care unit.Journal of intensive medicine · 2023
    Review
  10. Article
  11. Article
  12. Quantifying the effect of in-hospital antimicrobial use on the development of colistin-resistantEuropean journal of hospital pharmacy : science and practice · 2022
    Article
  13. Article
  14. Article
  15. An Outbreak of Carbapenem-ResistantFrontiers in cellular and infection microbiology · 2021
    Article
  16. Article
  17. Emergence of Polymyxin Resistance in Clinical Klebsiella pneumoniae Through Diverse Genetic Adaptations: A Genomic, Retrospective Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  18. Article
  19. Emergent Polymyxin Resistance: End of an Era?Open forum infectious diseases · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stefan E RichterDepartment of Pulmonology and Critical Care Medicine, University of California, Los Angeles, Los Angeles, California, USA richtermdphd@gmail.com.
Loren MillerInfectious Disease Clinical Outcome Research Unit, Los Angeles Biomedical Research Institute at Harbor-UCLA, Los Angeles, California, USA.
Daniel Z UslanDepartment of Infectious Disease, University of California, Los Angeles, Los Angeles, California, USA.
Douglas BellDepartment of Internal Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Karol WatsonNIH BD2K Center of Excellence at UCLA, University of California, Los Angeles, Los Angeles, California, USA.
Romney HumphriesDepartment of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, California, USA.
James A McKinnellInfectious Disease Clinical Outcome Research Unit, Los Angeles Biomedical Research Institute at Harbor-UCLA, Los Angeles, California, USA.
University of California, Los Angeles · USThe Lundquist Institute · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
TRAININGU54GM114833 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LINDSEY, MERRY L., PING, PEIPEI · 2014 to 2017
$13.8M
NCATS NIH HHS UL1 TR001881NIGMS NIH HHS U54 GM114833
6 · The paper itself

Abstract

Infections due to colistin-resistant (Col

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsClinical Decision-MakingColistinGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsRetrospective StudiesRisk FactorsAnti-Bacterial AgentsColistinantibiotic resistanceantibiotic stewardshipantimicrobial agentsantimicrobial testingclinical decision makingcolistinGram-negative bacteriaGram-negative rods

Identifiers

PMID29976595
PMCPMC6113453
OpenAlexW2879588449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.